Jan 21, 2019
Mount Joy resident Tim Card made history at Penn State Cancer Institute as the first recipient of CAR-T therapy. Follow his journey to remission.
Dec 5, 2018
By Abby Sajid For people with an aggressive form of non-Hodgkin lymphoma, treatments can be limited. Enter a new treatment called Yescarta. Yescarta, or axicabtagene ciloleucel, can be nothing short […]
Jun 21, 2018
Penn State Cancer Institute is now the first and only oncology center in central Pennsylvania to offer patients CAR T-cell therapy, a cutting-edge treatment that has been successful treating a common type of lymphoma.